Iomeron

Iomeprol, the active ingredient in Iomeron, is a iodinated contrast agent presented as an injection solution for intravenous use. It enhances radiodensity by absorbing X‑rays, thereby improving the visibility of anatomical structures during diagnostic imaging procedures such as computed tomography, angiography and urography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to facilitate import and distribution across multiple regions.

Iomeron is employed in diagnostic imaging to increase contrast between vascular and tissue structures.

- Contrast‑enhanced radiographic imaging: provides clearer delineation of bones and soft tissues for accurate diagnosis. - Computed tomography (CT) scans: heightens attenuation differences, facilitating detection of lesions and vascular abnormalities. - Angiography: outlines blood vessels and vascular lesions, improving visualization for interventional procedures.

Iomeprol may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Warm sensation at injection site - Metallic taste in mouth - Nausea - Vomiting - Headache - Mild itching or rash

Serious or Rare Side Effects: - Anaphylactic reaction (severe allergy) - Contrast‑induced nephropathy - Thyroid dysfunction (hyper‑ or hypothyroidism) - Severe hypotension - Cardiac arrhythmias

When using Iomeron, several precautionary measures should be observed to minimize risk.

- Renal impairment: assess kidney function (eGFR) before administration. - History of iodine allergy: consider alternative contrast agents or pre‑medication. - Thyroid disease: monitor thyroid function tests as iodine load may affect hormone levels. - Pregnancy: use only if essential, after evaluating benefit‑risk ratio. - Hydration: ensure adequate fluid intake before and after the procedure to support renal clearance. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Iomeron can interact with certain medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodine‑containing drugs (e.g., amiodarone, potassium iodide): may increase total iodine burden and risk of toxicity. - Nephrotoxic agents (e.g., aminoglycosides, NSAIDs, radiocontrast‑enhancing chemotherapy): heighten risk of renal injury.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of the contrast medium. - Metformin: consider temporary discontinuation in patients with impaired renal function to prevent lactic acidosis. - Beta‑blockers: no direct pharmacokinetic interaction but monitor hemodynamic status during imaging.